Treatment
-
March 29: The Week in Cancer NewsJury awards damages to man who says Roundup caused his cancer, the FDA proposes national standards for breast density notifications, and a physician questions whether patients with impaired renal function should avoid contrast-enhanced scans.
by Marci A. Landsmann
-
Forward Look
Some Prostate Cancer Patients Face a Difficult DecisionSurgery and radiation have similar benefits but different side effects.
by Stephen Ornes
-
Forward Look
Looking for Brain MetastasesStudies aim to identify when screening is beneficial.
by Sue Rochman
-
Forward Look
Lynch Syndrome Linked to More CancersStudy findings suggest patient screening has been too narrow.
by Sharon Tregaskis
-
Forward Look
What’s Next? Spring 2019Reducing chemotherapy side effects with a ‘drug sponge.'
by Bradley Jones
-
Keeping an Eye on CancerImaging tests for post-treatment surveillance may come with radiation exposure, financial strain, “scanxiety” and sometimes unnecessary follow-ups. Doctors and patients need to balance the risks and benefits of scanning.
by Charlotte Huff
-
More Options for Rare CancersPrecision medicine and immunotherapy offer opportunities for new treatments and clinical trials to patients who previously had few, if any, options.
by Kendall K. Morgan
-
The Patient PerspectivePatient-reported outcomes may help shape the future of cancer care.
by Stephen Ornes
-
Q&A
Hope Amid the HypeHematologist-oncologist David Scadden traces the history, promise and uncertainties of treatment advances in Cancerland: A Medical Memoir.
by Marci A. Landsmann
-
First Immunotherapy Approved for Breast CancerMedical oncologist Leisha A. Emens discusses the significance of the first U.S. Food and Drug Administration approval of an immunotherapy treatment for breast cancer.
by Anna Azvolinsky
